Quality Criteria for Essential Oils: What Standards and Pharmacopoeias Leave in the Shadows
Standards and pharmacopoeias currently constitute the main frameworks used to assess the quality of essential oils. They define analytical criteria intended to regulate production, marketing, and ultimately consumer safety. However, these frameworks rely on a limited set of parameters and leave significant blind spots. This article provides a critical reading of current reference systems and questions their ability to truly guarantee safety and authenticity.
Esméralda Cicchetti
7/16/20255 min read
Quality Criteria for Essential Oils: What Standards and Pharmacopoeias Leave in the Shadows
Standards and pharmacopoeias are today the main references used to assess the quality of essential oils. They define analytical criteria intended to regulate production, marketing, and ultimately product safety. But behind this apparent scientific rigor, grey areas remain. Can these documents truly be relied upon to guarantee the quality and safety of natural extracts? A critical analysis is required.
Partial reference frameworks: the “marker compounds” trap
Essential oils are complex mixtures containing several hundred volatile compounds. Yet pharmacopoeial monographs and standards (AFNOR, ISO, etc.) consider only a handful of so-called “marker compounds”, often around ten constituents, to determine batch compliance. This simplification has several major limitations:
It ignores the vast majority of constituents, among which some may be toxic even at low doses.
It disregards cumulative effects of molecules potentially present in trace amounts but originating from multiple oils in a synergistic formulation.
It facilitates falsification practices, allowing some unscrupulous operators to target only the compounds under analysis, adding synthetic substances or cheap oils to mimic expected characteristics.
In other words, what is not searched for is neither detected nor sanctioned.
Natural variability: an obstacle to standardisation
The chemical composition of an essential oil can vary significantly depending on plant geographic origin, climatic conditions, harvest season, cultivation method, or extraction technique. This natural variability, which constitutes part of the value of essential oils, conflicts with conformity requirements imposed by standards.
In this context, it becomes tempting—or even necessary—for some producers to adjust their extract (for example by rectification or fractionation) to meet defined thresholds. This raises a fundamental question: to what extent does regulatory compliance still reflect the natural character of an essential oil?
Region-dependent criteria
At international level, quality criteria differ from one pharmacopoeia to another. An essential oil considered compliant in Europe may not meet requirements in the United States or Asia. The lack of harmonisation of reference frameworks and variability in their application increase uncertainty regarding the real quality of products.
In some regions of the world, weak regulatory oversight further increases the risk of falsification. The scale of the global market, combined with the difficulty of controlling each batch, leaves significant room for malicious operators.
A contested simplification of contaminant analysis
In 2020, the European Pharmacopoeia introduced adjustments aimed at reducing contaminant testing for essential oils. It states that pesticides, heavy metals, or aflatoxins are not considered a critical risk for this type of product, thereby justifying the absence of systematic testing.
However, this position contradicts field reality. Several recent studies have reported pesticide residues in essential oils certified as organic. This finding questions the effectiveness of existing controls, including for labelled products.
The issue of expert independence
Standards and pharmacopoeias are written by expert groups belonging to national or international bodies. In practice, many experts come from the essential oil or natural raw materials industry. Some simultaneously sit on multiple standard-setting bodies, both at national level (e.g. ANSM, AFNOR) and international level (e.g. European Pharmacopoeia, ISO).
This dual role raises a major ethical issue: can quality criteria truly be impartial if they are directly or indirectly influenced by economic interests? In some working groups, more than half of the members are industry representatives—producers, processors, or distributors of essential oils used in aromatherapy, perfumery, or flavouring sectors.
Opacity of conflicts of interest
Although some organisations require disclosure of conflicts of interest, implementation remains inconsistent and often not transparent to the public. It is rare to have access to complete lists of affiliations or economic interests of experts involved in drafting standards. This lack of transparency fuels distrust regarding the scientific neutrality of reference frameworks.
Lagging behind fraud methods
Analytical methods prescribed by standards and pharmacopoeias remain relatively static, while falsification techniques evolve rapidly. Synthetic substances that perfectly mimic target markers, disguised dilutions using olfactory modifiers, or reconstructed oils made from isolated fractions make fraud increasingly difficult to detect.
Official controls, particularly those carried out by national agencies or the DGCCRF, struggle to keep pace. Control capacity covers only a fraction of products available on the market, especially those sold online. Studies have shown that most essential oils labelled “100% pure and natural” on the internet are in fact adulterated.
Training professionals to strengthen vigilance
Faced with this complexity, vigilance cannot rely solely on regulatory authorities. Training healthcare professionals, aromatherapy practitioners, and specialised sellers is a key lever to improve traceability and safety. However, many training programmes remain superficial regarding authenticity, quality issues, and risks linked to adulteration or formulation errors.
Integrating these topics into educational programmes, strengthening analytical capacity in practice, and encouraging controlled local supply chains are all potential ways to secure essential oil use.
Conclusion
Far from guaranteeing absolute quality, standards and pharmacopoeias provide a partial—and sometimes influenced—view of what a “compliant” essential oil should be. For informed users, healthcare professionals, or educators, it becomes essential to go beyond these frameworks, understand their limitations, and demand real traceability and transparency. Rigorous aromatherapy cannot exist without a critical examination of the tools that are supposed to ensure its safety.
For analytical support related to essential oils, contact us.
References
Challenges in the quality of herbal medicinal products with a specific focus on contaminants. Steinhoff, Barbara. 2019, Phytochemical Analysis, pp. 1-7.
Authenticity of essential oils. Thi Kieu Tiên Do, Francis Hadji-Minagloua,Sylvain Antoniotti,Xavier Fernandez. 2015, Trends in Analytical Chemistry, pp. (66), 146-157.
Botanical ingredient identification and quality assessment: strengths and limitations of analytical techniques. Glasl, Roy Upton . Bruno David . Stefan Gafner . Sabine. 2020, Phytochem Rev, pp. (19), 1157-1177.
On Problems of the Comprehensive Chemical Profiling of Medicinal Plants. S. V. Morozova, N. I. Tkacheva, and A. V. Tkacheva,. 2019, RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY , pp. (45:7), 860-875.
A Review on Impurity Profiling and its Regulatory Aspects- An important and necessary tool in stability studies. Ameena Yasmeen, Ghulamuddin Sofi, Kaleemullah Khan. 2020, Indo Global Journal of Pharmaceutical Sciences, pp. 10(1):57-68.
Quality standards of the European Pharmacopoeia. Anne-Sophie Bouin, Michael Wierer. 2014, Journal of Ethnopharmacology, pp. (158:2), 454-457.
Botanical Ingredient Forensics : Detection of Attempts to Deceive Commonly Used Analytical Methods for Authenticating Herbal Dietary and Food Ingredients and Supplements. Stefan Gafner, Mark Blumenthal, Steven Foster, John H.Cardellina, II, IkhlasA.Khan, and Roy Upton. 2023, J.Nat.Prod., pp. (86), 460-472.
Adulteration of Essential Oils: A Multitask Issue for Quality Control. Three Case Studies: Lavandula angustifolia Mill., Citrus limon (L.) Osbeck and Melaleuca alternifolia (Maiden & Betche) Cheel. Francesca Capetti, Arianna Marengo, Cecilia Cagliero, Erica Liberto, Carlo Bicchi, Patrizia Rubiolo, Barbara Sgorbini. 2021, Molecules, pp. (26), 5610-5623.
Quality Standards and Pharmacological Interventions of Natural Oils: Current Scenario and Future Perspectives. Shadab Ali, Rustam Ekbbal, Sapna Salar,, Sayad Ahad Ali, Aakash Kumar Jaiswal, Mhaveer Singh, Dinesh Kumar Yadav, Santosh Kumar. 2023, ACS Omega, pp. (8), 39945-39963.
New Ph. Eur. Chapter on Essential Oils. GMP Compliance. [En ligne] 05 2020. https://www.gmp-compliance.org/gmp-news/new-ph-eur-chapter-on-essential-oils.
Multiresidue in essential oils-Experience in SCL. DGCCRF. Stuttgart : Joint EURL Workshop, 10/2023.
Combating Barriers in Herbal Medicine Regulation: A Study of India, United States, And European Union. Kumar, Rajesh. 2025, European Economic Letters , pp. (15:1), 1-10.
ANSM. Décision du 8 juin 2007 portant nomination au groupe de travail Pharmacopée - huiles essentielles de l'Agence française de sécurité sanitaire des produits de santé. Légifrance. [En ligne] Texte n° 81 JORF n°144 du 23 juin 2007. https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000000464834.
Essential oils for clinical aromatherapy: A comprehensive review. Vora, Lalitkumar K. 2024, Journal of Ethnopharmacology, pp. (330), 118180.
ANSM. CP02 scéance n°12 . ANSM. [En ligne] 2016. https://archive.ansm.sante.fr/var/ansm_site/storage/original/application/33582fcf94a44de9d848c8b98108c398.pdf.
Marissa Pierson, Xavier Fernandez & Sylvain Antoniotti. Type and magnitude of non‑compliance and adulteration in neroli, mandarin and bergamot essential oils purchased on‑line: potential consumer vulnerability. Scientific Reports. 2021, Vol. 11, 11096.
36. Cano-Ortiz, A., Piñar Fuentes, J. C.,Maireles, C. R., & Cano, E. Education as a health tool: Adulterations and falsifications in natural medicine. Research Journal of Ecology and Environmental Sciences. 2024, Vol. 4, 1.
